Global Liver Cancer Therapeutics Market 2026 - Players, Regions, Product Types, Application & Forecast Analysis

Chapter 1 Liver Cancer Therapeutics Market Overview

1.1 Liver Cancer Therapeutics Definition

1.2 Global Liver Cancer Therapeutics Market Size Status and Outlook (2019-2032)

1.3 Global Liver Cancer Therapeutics Market Size Comparison by Region (2019-2032)

1.4 Global Liver Cancer Therapeutics Market Size Comparison by Type (2019-2032)

1.5 Global Liver Cancer Therapeutics Market Size Comparison by Application (2019-2032)

1.6 Global Liver Cancer Therapeutics Market Size Comparison by Sales Channel (2019-2032)

1.7 Liver Cancer Therapeutics Market Dynamics

1.7.1 Market Drivers/Opportunities

1.7.2 Market Challenges/Risks

1.7.3 Market News (Products Launch, Mergers, Acquisitions, Expansion, Agreement and Collaborations, Partnerships)

1.7.4 COVID-19 Impacts

1.7.5 Russia-Ukraine War Impacts

1.7.6 US-Israel-Iran War Impacts

Chapter 2 Executive Summary

2.1 Global Liver Cancer Therapeutics Market Snapshot

2.2 Global Liver Cancer Therapeutics Market Volume & Revenue (2019-2025)

2.3 Global Liver Cancer Therapeutics Market Differential Growth Potential Analysis by Type, (2019-2032) (USD Million)

2.4 Global Liver Cancer Therapeutics Market Differential Growth Potential Analysis by Application, (2019-2032) (USD Million)

2.5 Global Liver Cancer Therapeutics Market Differential Growth Potential Analysis by Sales Channels, (2019-2032) (USD Million)

2.6 Global Liver Cancer Therapeutics Market Differential Growth Potential Analysis by Region, (2019-2032) (USD Million)

Chapter 3 Liver Cancer Therapeutics Market Segment Analysis by Player

3.1 Global Liver Cancer Therapeutics Sales and Market Share by Player (2023-2025)

3.2 Global Liver Cancer Therapeutics Revenue and Market Share by Player (2023-2025)

3.3 Global Liver Cancer Therapeutics Average Price by Player (2023-2025)

3.4 Players Competition Situation & Trends (2023-2025)

3.5 Conclusion of Segment by Player

Chapter 4 Liver Cancer Therapeutics Market Segment Analysis by Type

4.1 Global Liver Cancer Therapeutics Market by Type

4.1.1 Targeted Therapy

4.1.2 Immunotherapy

4.1.3 Chemotherapy

4.1.4 Others

4.2 Global Liver Cancer Therapeutics Sales and Market Share by Type (2019-2025)

4.3 Global Liver Cancer Therapeutics Revenue and Market Share by Type (2019-2025)

4.4 Global Liver Cancer Therapeutics Average Price by Type (2019-2025)

4.5 Leading Players of Liver Cancer Therapeutics by Type in 2025

4.6 Conclusion of Segment by Type

Chapter 5 Liver Cancer Therapeutics Market Segment Analysis by Application

5.1 Global Liver Cancer Therapeutics Market by Application

5.1.1 Hospitals & Clinics

5.1.2 Retail Pharmacy

5.2 Global Liver Cancer Therapeutics Revenue and Market Share by Application (2019-2025)

5.3 Leading Consumers of Liver Cancer Therapeutics by Application in 2025

5.4 Conclusion of Segment by Application

Chapter 6 Liver Cancer Therapeutics Market Segment Analysis by Sales Channel

6.1 Global Liver Cancer Therapeutics Market by Sales Channel

6.1.1 Global Liver Cancer Therapeutics Market, by Direct Channel Market Analysis (2019-2032) (USD Million)

6.1.2 Global Liver Cancer Therapeutics Market, by Distribution Channel Market Analysis (2019-2032) (USD Million)

6.2 Global Liver Cancer Therapeutics Revenue and Market Share by Sales Channel (2019-2025)

6.3 Leading Distributors/Dealers of Liver Cancer Therapeutics by Sales Channel in 2025

6.4 Conclusion of Segment by Sales Channel

Chapter 7 Liver Cancer Therapeutics Market Segment Analysis by Region

7.1 Global Liver Cancer Therapeutics Market Size and CAGR by Region (2019-2032)

7.2 Global Liver Cancer Therapeutics Sales and Market Share by Region (2019-2025)

7.3 Global Liver Cancer Therapeutics Revenue and Market Share by Region (2019-2025)

7.4 North America

7.4.1 North America Market by Country

7.4.2 North America Liver Cancer Therapeutics Market Share by Type

7.4.3 North America Liver Cancer Therapeutics Market Share by Application

7.4.4 United States

7.4.5 Canada

7.4.6 Mexico

7.5 Europe

7.5.1 Europe Market by Country

7.5.2 Europe Liver Cancer Therapeutics Market Share by Type

7.5.3 Europe Liver Cancer Therapeutics Market Share by Application

7.5.4 Germany

7.5.5 United Kingdom

7.5.6 France

7.5.7 Italy

7.5.8 Russia

7.5.9 Spain

7.5.10 Benelux

7.5.11 Poland

7.5.12 Austria

7.5.13 Portugal

7.5.14 Rest of Europe

7.6 Asia-Pacific

7.6.1 Asia-Pacific Market by Country

7.6.2 Asia-Pacific Liver Cancer Therapeutics Market Share by Type

7.6.3 Asia-Pacific Liver Cancer Therapeutics Market Share by Application

7.6.4 China

7.6.5 Japan

7.6.6 Korea

7.6.7 India

7.6.8 Southeast Asia

7.6.9 Australia

7.6.10 Taiwan

7.6.11 Rest of Asia Pacific

7.7 South America

7.7.1 South America Market by Country

7.7.2 South America Liver Cancer Therapeutics Market Share by Type

7.7.3 South America Liver Cancer Therapeutics Market Share by Application

7.7.4 Brazil

7.7.5 Argentina

7.7.6 Colombia

7.7.7 Chile

7.7.8 Peru

7.7.9 Venezuela

7.7.10 Rest of South America

7.8 Middle East & Africa

7.8.1 Middle East & Africa Market by Country

7.8.2 Middle East & Africa Liver Cancer Therapeutics Market Share by Type

7.8.3 Middle East & Africa Liver Cancer Therapeutics Market Share by Application

7.8.4 UAE

7.8.5 Saudi Arabia

7.8.6 South Africa

7.8.7 Egypt

7.8.8 Nigeria

7.9.9 Rest of Middle East & Africa

7.9 Conclusion of Segment by Region

Chapter 8 Profile of Leading Liver Cancer Therapeutics Players

8.1 Exelixis

8.1.1 Company Snapshot

8.1.2 Product/Service Offered

8.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.1.4 Recent Developments

8.2 Merck

8.2.1 Company Snapshot

8.2.2 Product/Service Offered

8.2.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.2.4 Recent Developments

8.3 Imunon (Celsion)

8.3.1 Company Snapshot

8.3.2 Product/Service Offered

8.3.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.3.4 Recent Developments

8.4 Roche

8.4.1 Company Snapshot

8.4.2 Product/Service Offered

8.4.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.4.4 Recent Developments

8.5 Pfizer

8.5.1 Company Snapshot

8.5.2 Product/Service Offered

8.5.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.5.4 Recent Developments

8.6 Eisai

8.6.1 Company Snapshot

8.6.2 Product/Service Offered

8.6.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.6.4 Recent Developments

8.7 Eli Lilly and Company

8.7.1 Company Snapshot

8.7.2 Product/Service Offered

8.7.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.7.4 Recent Developments

8.8 BeiGene

8.8.1 Company Snapshot

8.8.2 Product/Service Offered

8.8.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.8.4 Recent Developments

8.9 AbbVie

8.9.1 Company Snapshot

8.9.2 Product/Service Offered

8.9.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.9.4 Recent Developments

8.10 Novartis

8.10.1 Company Snapshot

8.10.2 Product/Service Offered

8.10.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.10.4 Recent Developments

8.11 ...

8.11.1 Company Snapshot

8.11.2 Product/Service Offered

8.11.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.11.4 Recent Developments

8.12 Others

8.12.1 Company Snapshot

8.12.2 Product/Service Offered

8.12.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.12.4 Recent Developments

Chapter 9 Upstream and Downstream Analysis of Liver Cancer Therapeutics

9.1 Industrial Chain of Liver Cancer Therapeutics

9.2 Upstream of Liver Cancer Therapeutics

9.2.1 Raw Materials (If Applicable)

9.2.2 Manufacturing Cost Structure (If Applicable)

9.2.3 Manufacturing Process (If Applicable)

9.3 Downstream of Liver Cancer Therapeutics

9.3.1 Leading Distributors/Dealers of Liver Cancer Therapeutics

9.3.2 Leading Consumers of Liver Cancer Therapeutics

Chapter 10. Global Liver Cancer Therapeutics Market Industry Analysis

10.1. Porter's Five Forces Analysis

10.1.1. Threat of New Entrants

10.1.2. Bargaining Power of Buyers/Consumers

10.1.3. Bargaining Power of Suppliers

10.1.4. Threat of Substitute Types

10.1.5. Intensity of Competitive Rivalry

10.2. Major Growth Avenues within Global Liver Cancer Therapeutics Market

10.2.1. Product Types

10.2.2. Applications

10.2.3. Sales Channels

10.2.4. Country

10.3. Liver Cancer Therapeutics Industry Ecosystem

10.4. Price Trend Analysis (If Applicable)

10.5. Buying Criteria (If Applicable)

10.6. Regulations (If Applicable)

Chapter 11 Development Trend of Liver Cancer Therapeutics (2026-2032)

11.1 Global Liver Cancer Therapeutics Market Size (Sales and Revenue) Forecast (2026-2032)

11.2 Global Liver Cancer Therapeutics Market Size and CAGR Forecast by Region (2026-2032)

11.3 Global Liver Cancer Therapeutics Market Size and CAGR Forecast by Type (2026-2032)

11.4 Global Liver Cancer Therapeutics Market Size and CAGR Forecast by Application (2026-2032)

11.5 Global Liver Cancer Therapeutics Market Size and CAGR Forecast by Sales Channel (2026-2032)

Chapter 12. Import - Export Analysis (If Applicable)

12.1 North America Liver Cancer Therapeutics Import-Export (2019-2025)

12.2 Europe Liver Cancer Therapeutics Import-Export (2019-2025)

12.3 Asia Pacific Liver Cancer Therapeutics Import-Export (2019-2025)

12.4 South America Liver Cancer Therapeutics Import-Export (2019-2025)

12.5 Middle East & Africa Liver Cancer Therapeutics Import-Export (2019-2025)

Chapter 13. Demand-Supply Gap Analysis

13.1 North America Liver Cancer Therapeutics Demand-Supply (2019-2025)

13.2 Europe Liver Cancer Therapeutics Demand-Supply (2019-2025)

13.3 Asia Pacific Liver Cancer Therapeutics Demand-Supply (2019-2025)

13.4 South America Liver Cancer Therapeutics Demand-Supply (2019-2025)

13.5 Middle East & Africa Liver Cancer Therapeutics Demand-Supply (2019-2025)

Chapter 14 Appendix

14.1 Research Methodology

14.2 Data Sources